US 4458066A
· Caruthers et al.
· 1984
[cited by applicant]
US 4683202A
· Mullis
· 1987
[cited by applicant]
US 4988617A
· Landegren et al.
· 1991
[cited by applicant]
US 5143854A
· Pirrung et al.
· 1992
[cited by applicant]
US 5242794A
· Whiteley et al.
· 1993
[cited by applicant]
US 5299491A
· Kawada
· 1994
[cited by applicant]
US 5382510A
· Levine et al.
· 1995
[cited by applicant]
US 5403708A
· Brennan et al.
· 1995
[cited by applicant]
US 5412087A
· McGall et al.
· 1995
[cited by applicant]
US 5432065A
· Fuller
· 1995
[cited by applicant]
US 5472672A
· Brennan
· 1995
[cited by applicant]
US 5494810A
· Barany et al.
· 1996
[cited by applicant]
US 5641658A
· Adams et al.
· 1997
[cited by applicant]
US 5928907A
· Woudenberg et al.
· 1999
[cited by applicant]
US 6015674A
· Woudenberg et al.
· 2000
[cited by applicant]
US 6045996A
· Cronin et al.
· 2000
[cited by applicant]
US 6156504A
· Gocke et al.
· 2000
[cited by applicant]
US 6420117B1
· Wessler et al.
· 2002
[cited by applicant]
US 6582938B1
· Su et al.
· 2003
[cited by applicant]
US 6754655B1
· Segal
· 2004
[cited by applicant]
US 6818395B1
· Quake et al.
· 2004
[cited by applicant]
US 7169560B2
· Lapidus et al.
· 2007
[cited by applicant]
US 7211390B2
· Rothberg et al.
· 2007
[cited by applicant]
US 7211654B2
· Gao et al.
· 2007
[cited by applicant]
US 7244559B2
· Rothberg et al.
· 2007
[cited by applicant]
US 7264929B2
· Rothberg et al.
· 2007
[cited by applicant]
US 7280922B2
· Mei et al.
· 2007
[cited by applicant]
US 7282337B1
· Harris
· 2007
[cited by applicant]
US 7300788B2
· Matsuzaki et al.
· 2007
[cited by applicant]
US 7323305B2
· Leamon et al.
· 2008
[cited by applicant]
US 7335762B2
· Rothberg et al.
· 2008
[cited by applicant]
US 7361488B2
· Fan et al.
· 2008
[cited by applicant]
US 7534561B2
· Sana et al.
· 2009
[cited by applicant]
US 7582420B2
· Oliphant et al.
· 2009
[cited by applicant]
US 7785783B2
· Morley et al.
· 2010
[cited by applicant]
US 7803550B2
· Makarov et al.
· 2010
[cited by applicant]
US 8026094B2
· Green et al.
· 2011
[cited by applicant]
US 8133719B2
· Drmanac et al.
· 2012
[cited by applicant]
US 8140270B2
· Kingsmore et al.
· 2012
[cited by applicant]
US 8296076B2
· Fan et al.
· 2012
[cited by applicant]
US 8318430B2
· Chuu et al.
· 2012
[cited by applicant]
US 8323897B2
· Andersen et al.
· 2012
[cited by applicant]
US 8415101B2
· Garner
· 2013
[cited by applicant]
US 8417459B2
· Reese et al.
· 2013
[cited by applicant]
US 8532930B2
· Rabinowitz et al.
· 2013
[cited by applicant]
US 8589175B2
· Glauser et al.
· 2013
[cited by applicant]
US 8785353B2
· Van Eijk et al.
· 2014
[cited by applicant]
US 8862410B2
· Hatchwell et al.
· 2014
[cited by applicant]
US 9051602B2
· Oliphant et al.
· 2015
[cited by applicant]
US 9109256B2
· Shuber
· 2015
[cited by applicant]
US 9128861B2
· Bartha et al.
· 2015
[cited by applicant]
US 9183496B2
· Harris et al.
· 2015
[cited by applicant]
US 9228232B2
· Faham et al.
· 2016
[cited by applicant]
US 9329170B2
· Clarke et al.
· 2016
[cited by applicant]
US 9416422B2
· Cheung
· 2016
[cited by applicant]
US 9453257B2
· Hoyal-Wrightson et al.
· 2016
[cited by applicant]
US 9512485B2
· Richardson et al.
· 2016
[cited by applicant]
US 9523121B2
· Spier et al.
· 2016
[cited by applicant]
US 9725755B2
· Poole et al.
· 2017
[cited by applicant]
US 9727692B2
· Harris et al.
· 2017
[cited by applicant]
US 9745626B2
· Bartha et al.
· 2017
[cited by applicant]
US 9909186B2
· Schuetz et al.
· 2018
[cited by applicant]
US 10255330B2
· Chandratillake et al.
· 2019
[cited by applicant]
US 20030022200A1
· Vissing et al.
· 2003
[cited by applicant]
US 20030096011A1
· Tracy et al.
· 2003
[cited by applicant]
US 20030100995A1
· Loraine et al.
· 2003
[cited by applicant]
US 20050042668A1
· Perlin
· 2005
[cited by applicant]
US 20050086035A1
· Peccoud et al.
· 2005
[cited by applicant]
US 20050250125A1
· Novakoff
· 2005
[cited by applicant]
US 20060184489A1
· Weiner et al.
· 2006
[cited by applicant]
US 20060278241A1
· Ruano
· 2006
[cited by applicant]
US 20070111247A1
· Stephens et al.
· 2007
[cited by applicant]
US 20070184436A1
· Myerson et al.
· 2007
[cited by applicant]
US 20080096766A1
· Lee
· 2008
[cited by applicant]
US 20080305473A1
· Chowdary et al.
· 2008
[cited by applicant]
US 20090029364A1
· Zirwes et al.
· 2009
[cited by applicant]
US 20090326832A1
· Heckerman et al.
· 2009
[cited by applicant]
US 20100029498A1
· Gnirke et al.
· 2010
[cited by applicant]
US 20100035252A1
· Rothberg et al.
· 2010
[cited by applicant]
US 20100042438A1
· Moore et al.
· 2010
[cited by applicant]
US 20100137143A1
· Rothberg et al.
· 2010
[cited by applicant]
US 20100301398A1
· Rothberg et al.
· 2010
[cited by applicant]
US 20110004413A1
· Carnevali et al.
· 2011
[cited by applicant]
US 20120015050A1
· Abkevich et al.
· 2012
[cited by applicant]
US 20120058480A1
· Lewis et al.
· 2012
[cited by applicant]
US 20120143512A1
· Reese et al.
· 2012
[cited by applicant]
US 20120270206A1
· Ginns et al.
· 2012
[cited by applicant]
US 20130102477A1
· Morin et al.
· 2013
[cited by applicant]
US 20130173177A1
· Pelleymounter
· 2013
[cited by applicant]
US 20130178389A1
· Lapidus et al.
· 2013
[cited by applicant]
US 20130261196A1
· Diamond et al.
· 2013
[cited by applicant]
US 20130311448A1
· Thompson
· 2013
[cited by applicant]
US 20130332081A1
· Reese et al.
· 2013
[cited by applicant]
US 20140186827A1
· Pieprzyk et al.
· 2014
[cited by applicant]
US 20150057160A1
· Breuer et al.
· 2015
[cited by applicant]
US 20160032396A1
· Diehn et al.
· 2016
[cited by applicant]
US 20160041987A1
· Lapir et al.
· 2016
[cited by applicant]
US 20160092631A1
· Yandell et al.
· 2016
[cited by applicant]
US 20170166981A1
· Craig et al.
· 2017
[cited by applicant]
US 20170199961A1
· Yelensky et al.
· 2017
[cited by applicant]
US 20170253921A1
· Liu et al.
· 2017
[cited by applicant]
US 20180203974A1
· Venn
· 2018
[cited by applicant]
US 20180282801A1
· Zhao et al.
· 2018
[cited by applicant]
US 20180363066A1
· Chalmers et al.
· 2018
[cited by applicant]
US 20190285518A1
· Lu et al.
· 2019
[cited by applicant]
US 20190346442A1
· Carr et al.
· 2019
[cited by applicant]
US 20200024669A1
· Spetzler et al.
· 2020
[cited by applicant]
US 20200048711A1
· Snyder
· 2020
[cited by applicant]
US 20200202224A1
· Lanman et al.
· 2020
[cited by applicant]
US 20200258601A1
· Lau
· 2020
[cited by applicant]
US 20200392584A1
· Almogy et al.
· 2020
[cited by applicant]
US 20210304841A1
· Renzi
· 2021
[cited by examiner]
US 20210398609A1
· Sigurjonsson et al.
· 2021
[cited by applicant]
US 20220064733A1
· Alexander et al.
· 2022
[cited by applicant]
US 20220073985A1
· Nerenberg et al.
· 2022
[cited by applicant]
US 20220081716A1
· West et al.
· 2022
[cited by applicant]
US 20220195530A1
· Diehn et al.
· 2022
[cited by applicant]
US 20220344005A1
· Molyneaux et al.
· 2022
[cited by applicant]
CN 105044108A
· 2015
[cited by applicant]
CN 109903811A
· 2019
[cited by applicant]
EP 0281927B1
· 1995
[cited by applicant]
EP 1342794B1
· 2005
[cited by applicant]
EP 2861788B1
· 2018
[cited by applicant]
EP 3212808B1
· 2022
[cited by applicant]
WO 2000018957A1
· 2000
[cited by applicant]
WO 2005098046A2
· 2005
[cited by applicant]
WO 2007055244A1
· 2007
[cited by applicant]
WO 2010054589A1
· 2010
[cited by applicant]
WO 2011050341A1
· 2011
[cited by applicant]
WO 2011057061A1
· 2011
[cited by applicant]
WO 2011057094A1
· 2011
[cited by applicant]
WO 2011091046A1
· 2011
[cited by applicant]
WO 2011149534A2
· 2011
[cited by applicant]
WO 2011160063A2
· 2011
[cited by applicant]
WO 2011160206A1
· 2011
[cited by applicant]
WO 2012142611A2
· 2012
[cited by applicant]
WO 2014053295A1
· 2014
[cited by applicant]
WO 2014062717A1
· 2014
[cited by applicant]
WO 2014113204A1
· 2014
[cited by applicant]
WO 2014207245A1
· 2014
[cited by applicant]
WO 2015051275A1
· 2015
[cited by applicant]
WO 2015095889A2
· 2015
[cited by applicant]
WO 2016070131A1
· 2016
[cited by applicant]
WO 2017205823A1
· 2017
[cited by applicant]
WO 2018053365A1
· 2018
[cited by applicant]
WO 2018064547A1
· 2018
[cited by applicant]
WO 2018144782A1
· 2018
[cited by applicant]
WO 2018195357A1
· 2018
[cited by applicant]
WO 2018222883A1
· 2018
[cited by applicant]
WO 2019168984A1
· 2019
[cited by applicant]
WO 2019226939A1
· 2019
[cited by applicant]
WO 2019231856A1
· 2019
[cited by applicant]
WO 2020132586A1
· 2020
[cited by applicant]
WO 2020168008A1
· 2020
[cited by applicant]
WO 2020252721A1
· 2020
[cited by applicant]
WO 2021016089A1
· 2021
[cited by applicant]
WO 2022046947A1
· 2022
[cited by applicant]
Ralph et al. “Consistency of VDJ rearrangement and substitution parameters enables accurate B cell receptor sequence annotation.” PLoS computational biology 12.1 (2016): 1-25.
[cited by applicant]
Riaz et al. “Tumor and microenvironment evolution during immunotherapy with nivolumab.” Cell 171.4 (2017): 934-949.
[cited by applicant]
Richter, S. “Fecal DNA screening in colorectal cancer.” Canadian Journal of Gastroenterology and Hepatology 22.7 (2008): 631-633.
[cited by applicant]
Riester et al. “PureCN: copy number calling and SNV classification using targeted short read sequencing.” Source Code for Biology and Medicine 11.13 (2016): 1-13.
[cited by applicant]
Roberts et al. “The predictive capacity of personal genome sequencing.” Science translational medicine 4.133 (2012): 1-9.
[cited by applicant]
Robinson et al. “Strategies for exome and genome sequence data analysis in disease-gene discovery projects.” Clinical genetics 80.2 (2011): 127-132.
[cited by applicant]
Robinson et al. “The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease.” The American Journal of Human Genetics 83.5 (2008): 610-615.
[cited by applicant]
Rogozin et al. “Somatic mutation hotspots correlate with DNA polymerase n error spectrum.” Nature immunology 2.6 (2001): 530-536.
[cited by applicant]
Rosenfeld et al. “Novel multi-nucleotide polymorphisms in the human genome characterized by whole genome and exome sequencing.” Nucleic acids research 38.18 (2010): 6102-6111.
[cited by applicant]
Ross et al. “Characterizing and measuring bias in sequence data.” Genome biology 14 (2013): 1-20.
[cited by applicant]
Ross et al. “Whole cancer genome sequencing by next-generation methods.” American journal of clinical pathology 136.4 (2011): 527-539.
[cited by applicant]
Ross, D. “Introduction to oncogenes and molecular cancer medicine.” Springer Science & Business Media (1998): 1-10.
[cited by applicant]
Saeys et al. “A review of feature selection techniques in bioinformatics.” Bioinformatics 23.19 (2007): 2507-2517.
[cited by applicant]
Sahraeian et al. “Deep convolutional neural networks for accurate somatic mutation detection.” Nature communications 10.1 (2019): 1-10.
[cited by applicant]
Saiki et al. “Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes.” Nature 324.6093 (1986): 163-166.
[cited by applicant]
Sambrook et al. “Molecular cloning: A Laboratory Manual.” 4th ed, 448 (2012): 1-26.
[cited by applicant]
Samuels et al. “Genetic mosaics and the germ line lineage.” Genes 6.2 (2015): 216-237.
[cited by applicant]
Sandri et al. “Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise.” FEBS letters 373.3 (1995): 291-295.
[cited by applicant]
Saunders et al. “Strelka: accurate somatic small-variant calling from sequenced tumor normal sample pairs.” Bioinformatics 28.14 (2012): 1811-1817.
[cited by applicant]
Schmitt et al. “Detection of ultra-rare mutations by next-generation sequencing.” Proceedings of the National Academy of Sciences 109.36 (2012): 14508-14513.
[cited by applicant]
Schwarzenbach et al. “Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer.” Annals of the New York Academy of Sciences 1137.1 (2008): 190-196.
[cited by applicant]
Scitable. “Mendelian Trait.” Scitable by Nature Education, 2014. Retrieved from the Internet: <URL:https://web.archive.org/web/20140825124707/https://www.nature.com/scitable/definition/mendelian-trait-174/>, 2 pages.
[cited by applicant]
Sequence Alignment/Map Format Specification, Manual [online], The SAM/BAM Format Specification Working Group, 2024. Retrieved from the Internet: <URL:https://samtools.github.io/hts-specs/SAMv1.pdf>, 23 pages.
[cited by applicant]
Shapiro, E. “The human cell lineage flagship initiative.” Lineage-flagship.eu, 2010. Retrieved from the Internet: <URL:http://www.lineage-flagship.eu/>, 1 page.
[cited by applicant]
Shaw et al. “Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.” Genome research 22.2 (2012): 220-231.
[cited by applicant]
Shendure et al. “Next-generation DNA sequencing.” Nature biotechnology 26.10 (2008): 1135-1145.
[cited by applicant]
Shigemizu et al. “A practical method to detect SNVs and indels from whole genome and exome sequencing data.” Scientific reports 3.1 (2013): 1-6.
[cited by applicant]
Shigemizu et al. “A practical method to detect SNVs and indels from whole genome and exome sequencing data.” Supplementary Information. Scientific reports 3.1 (2013): 1-3.
[cited by applicant]
Shim et al. “HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L) 1 blockade in advanced non-small-cell lung cancer patients.” Annals of Oncology 31.7 (202…
[cited by applicant]
Sims et al. “Sequencing depth and coverage: key considerations in genomic analyses.” Nature Reviews Genetics 15.2 (2014): 121-132.
[cited by applicant]
Singleton et al. “Phevor combines multiple biomedical ontologies for accurate identification of disease-causing alleles in single individuals and small nuclear families.” The American Journal of Human Genetics 94.4 (201…
[cited by applicant]
Smyth, G. “Limma: linear models for microarray data.” Bioinformatics and computational biology solutions using R and Bioconductor. New York, NY: Springer New York (2005): 397-420.
[cited by applicant]
Snyder et al. “Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma.” New England Journal of Medicine (2014): 1-11.
[cited by applicant]
Song et al. “A reference methylome database and analysis pipeline to facilitate integrative and comparative epigenomics.” PloS one 8.12 (2013): 1-9.
[cited by applicant]
Soni et al. “Progress toward ultrafast DNA sequencing using solid-state nanopores.” Clinical chemistry 53.11 (2007): 1996-2001.
[cited by applicant]
Spalding et al. “Retrospective birth dating of cells in humans.” Cell 122.1 (2005): 133-143.
[cited by applicant]
Stemmer et al. “Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides.” Gene 164.1 (1995): 49-53.
[cited by applicant]
Stevanovic et al. “Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.” Science 356.6334 (2017): 200-205.
[cited by applicant]
Sudhakar et al. “Characterization of clonal immunoglobulin heavy (IGH) VDJ gene rearrangements and the complementarity-determining region in South Indian patients with precursor B-cell acute lymphoblastic leukemia.” Blo…
[cited by applicant]
Sulston et al. “Post-embryonic cell lineages of the nematode, Caenorhabditis elegans.” Developmental biology 56.1 (1977): 110-156.
[cited by applicant]
Sulston et al. “The embryonic cell lineage of the nematode Caenorhabditis elegans.” Developmental biology 100.1 (1983): 64-119.
[cited by applicant]
Summerer et al. “Targeted high throughput sequencing of a cancer-related exome subset by specific sequence capture with a fully automated microarray platform.” Genomics 95.4 (2010): 241-246.
[cited by applicant]
Sun et al. “Optimized data representation and convolutional neural network model for predicting tumor purity.” bioRxiv (2019): 1-9.
[cited by applicant]
Sung et al. “Assessment of intratumoral heterogeneity with mutations and gene expression profiles.” PLoS One 14.7 (2019): 1-15.
[cited by applicant]
SVBio. “SVBio's Services.” Company Information [online], SVBio, 2014. Retrieved from the Internet: <URL:http:www.svbio.com/service-offerings/current-services>, 1 page.
[cited by applicant]
Swanton, C. “Plasma-derived tumor DNA analysis at whole-genome resolution.” Clinical Chemistry 59.1 (2013): 6-8.
[cited by applicant]
Teer et al. “Exome sequencing: the sweet spot before whole genomes.” Human molecular genetics 19.R2 (2010): R145-R151.
[cited by applicant]
Tests and Procedures: Urine cytology, Definition [online], Mayo Clinic, 2014 [retrieved on Dec. 1, 2015]. Retrieved from the Internet: <URL:http://www.mayoclinic.org/tests-procedures/urine-cytology/basics/definition/prc…
[cited by applicant]
Tewhey et al. “Microdroplet-based PCR enrichment for large-scale targeted sequencing.” Nature biotechnology 27.11 (2009): 1025-1031.
[cited by applicant]
Tug et al. “Exercise-induced increases in cell free DNA in human plasma originate predominantly from cells of the haematopoietic lineage.” Exercise immunology review 21 (2015): 164-173.
[cited by applicant]
Turajlic et al. “Whole genome sequencing of matched primary and metastatic acral melanomas.” Genome research 22.2 (2012): 196-207.
[cited by applicant]
Turajlic et al. “Whole genome sequencing of matched primary and metastatic acral melanomas.” Supplementary Figures. Genome research 22.2 (2012): 1-43.
[cited by applicant]
Turajlic et al. “Whole genome sequencing of matched primary and metastatic acral melanomas.” Supplementary Tables. Genome research 22.2 (2012): 1-532.
[cited by applicant]
Vaisvila et al. “EM-seq: detection of DNA methylation at single base resolution from picograms of DNA.” BioRxiv (2019): 1-38.
[cited by applicant]
Valadi et al. “Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.” Nature cell biology 9.6 (2007): 654-659.
[cited by applicant]
Vale et al. “Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis.” Cancer treatment reviews 38.6 (2012): 618-625.
[cited by applicant]
Van Driel et al. “A text-mining analysis of the human phenome.” European journal of human genetics 14.5 (2006): 535-542.
[cited by applicant]
Varscan. “Variant Detection in Massively Parallel Sequencing Data.” VarScan, 2009. Retrieved from the Internet: <URL:www.varscan.sourceforge.net.>, 4 pages.
[cited by applicant]
Vasan, R. “Biomarkers of cardiovascular disease: molecular basis and practical considerations.” Circulation 113.19 (2006): 2335-2362.
[cited by applicant]
Velculescu et al. “Characterization of the yeast transcriptome.” Cell 88.2 (1997): 243-251.
[cited by applicant]
Velculescu et al. “Serial analysis of gene expression.” Science 270.5235 (1995): 484-487.
[cited by applicant]
Vietsch et al. “Circulating DNA and micro-RNA in patients with pancreatic cancer.” Pancreatic disorders & therapy 5.2 (2015): 1-17.
[cited by applicant]
Vinay et al. “Immune evasion in cancer: Mechanistic basis and therapeutic strategies.” Seminars in cancer biology. vol. 35. Academic Press (2015): S185-S198.
[cited by applicant]
Vincent et al. “Helicase-dependent isothermal DNA amplification.” EMBO reports 5.8 (2004): 795-800.
[cited by applicant]
Vos et al. “AFLP: a new technique for DNA fingerprinting.” Nucleic acids research 23.21 (1995): 4407-4414.
[cited by applicant]
Wagle et al. “High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.” Cancer discovery 2.1 (2012): 82-93.
[cited by applicant]
Walker et al. “Strand displacement amplification an isothermal, in vitro DNA amplification technique.” Nucleic acids research 20.7 (1992): 1691-1696.
[cited by applicant]
Wang et al. “Clonal evolution in breast cancer revealed by single nucleus genome sequencing.” Nature 512.7513 (2014): 155-160.
[cited by applicant]
Wang, K. “ANNOVAR Documentation.” Datasheet [online], ANNOVAR, 2010. Retrieved from the Internet: <URL: https://annovar.openbioinformatics.org/en/latest/>, 7 pages.
[cited by applicant]
Warren et al. “Targeted assembly of short sequence reads.” PloS one 6.5 (2011): 1-6.
[cited by applicant]
Wasserstrom et al. “Reconstruction of cell lineage trees in mice.” PloS one 3.4 (2008): 1-11.
[cited by applicant]
Westin et al. “Anchored multiplex amplification on a microelectronic chip array.” Nature Biotechnology 18.2 (2000): 199-204.
[cited by applicant]
Wikipedia. “Gradient boosting.” Wikipedia, 2020. Retrieved from the Internet: <URL:https://en.wikipedia.org/w/index.php?title=Gradient_boosting&oldid=957594903>, 8 pages.
[cited by applicant]
Wright et al. “The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis.” Human reproduction update 15.1 (2009): 139-151.
[cited by applicant]
Xiao et al. “Identifying mRNA, microRNA and protein profiles of melanoma exosomes.” PLoS One 7.10 (2012): 1-15.
[cited by applicant]
Yang et al. “Clinical whole-exome sequencing for the diagnosis of mendelian disorders.” New England Journal of Medicine 369.16 (2013): 1502-1511.
[cited by applicant]
Yeung et al. “LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma.” Clinical Cancer Research 19.7 (2013): 1816-1826.
[cited by applicant]
Yi et al. “Sequencing of fifty human exomes reveals adaptation to high altitude.” Science 329.5987 (2010): 75-78.
[cited by applicant]
Yu et al. “Chapter 3 MarkDuplicates: A practical introduction to GATK 4 on Biowulf.” GATK, 2021 [retrieved on Jun. 16, 2022]. Retrieved from the Internet: <URL:https://hpc.nih.gov/training/gatk_tutorial/markdup.html>, 6…
[cited by applicant]
Yu et al. “Mung bean nuclease treatment increases capture specificity of microdroplet-PCR based targeted DNA enrichment.” Plos one 9.7 (2014): 1-7.
[cited by applicant]
Zeerleder, S. “The struggle to detect circulating DNA.” Critical Care 10 (2006): 1-3.
[cited by applicant]
Zheng et al. “Estimating and accounting for tumor purity in the analysis of DNA methylation data from cancer studies.” Genome biology 18 (2017): 1-14.
[cited by applicant]
Griewank et al. “Genetic alterations and personalized medicine in melanoma: progress and future prospects.” Journal of the National Cancer Institute 106.2 (2014): 1-17.
[cited by applicant]
Ju et al. “Extensive genomic and transcriptional diversity identified through massively parallel DNA and RNA sequencing of eighteen Korean individuals.” Nature genetics, 43(8), pp. 745-752. Available at: https://doi.org…
[cited by applicant]
Ju et al. “A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.” Genome Research, 22(3), pp. 436-445. Available at: https://doi.org/10.1101/gr.133645.1…
[cited by applicant]
Seo et al. “The transcriptional landscape and mutational profile of lung adenocarcinoma.” Genome Research, 22(11), pp. 2109-2119. Available at: https://doi.org/10.1101/gr.145144.112. (2012).
[cited by applicant]
Shah et al. “Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution.” Nature, 461 (7265), pp. 809-813. Available at: https://doi.org/10.1038/nature08489. (2009).
[cited by applicant]
Dawe et al. “Cell migration from baby to mother.” Cell adhesion & migration 1.1 (2007): 19-27.
[cited by applicant]
Dawson et al. “Analysis of circulating tumor DNA to monitor metastatic breast cancer.” New England Journal of Medicine 368.13 (2013): 1199-1209.
[cited by applicant]
De La Chapelle, A. “The incidence of Lynch syndrome.” Familial cancer 4 (2005): 233-237.
[cited by applicant]
De Mattos-Arruda et al. “Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.” Annals of oncology 25.9 (2014): 1729-1735.
[cited by applicant]
De Mattos-Arruda et al. “Circulating tumour cells and cell-free DNA as tools for managing breast cancer.” Nature reviews Clinical oncology 10.7 (2013): 377-389.
[cited by applicant]
Decathelineau et al. “The final step in programmed cell death: phagocytes carry apoptotic cells to the grave.” Essays in biochemistry 39 (2003): 105-117.
[cited by applicant]
Dewey et al. “Phased whole-genome genetic risk in a family quartet using a major allele reference sequence.” PLoS genetics 7.9 (2011): 1-15.
[cited by applicant]
Diaz et al. “Insights into therapeutic resistance from whole-genome analyses of circulating tumor DNA.” Oncotarget 4.10 (2013): 1856-1857.
[cited by applicant]
Diaz et al. “Liquid biopsies: genotyping circulating tumor DNA.” Journal of clinical oncology 32.6 (2014): 579-586.
[cited by applicant]
Diehl et al. “Detection and quantification of mutations in the plasma of patients with colorectal tumors.” Proceedings of the National Academy of Sciences 102.45 (2005): 16368-16373.
[cited by applicant]
Ding et al. “Genome remodelling in a basal-like breast cancer metastasis and xenograft.” Nature 464.7291 (2010): 999-1005.
[cited by applicant]
Dressman et al. “Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations.” Proceedings of the National Academy of Sciences 100.15 (2003): 8817-8822.
[cited by applicant]
Drmanac et al. “Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays.” Science 327.5961 (2010): 78-81.
[cited by applicant]
EcSeq. “How to calculate the coverage for a NGS experiment.” ecSeq Bioinformatics, 2019 [retrieved on Jul. 5, 2022]. Retrieved from the Internet: <URL:https://www.ecseq.com/support/ngs/how-to-calculate-the-coverage-for-…
[cited by applicant]
Ellinger et al. “The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer.” Urologic Oncology: Seminars and Original Investigations, Elsevier 29.2 (2011): 124-129.
[cited by applicant]
Elsharawy et al. “Accurate variant detection across non-amplified and whole genome amplified DNA using targeted next generation sequencing.” BMC genomics 13 (2012): 1-14.
[cited by applicant]
Elshimali et al. “The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.” International journal of molecular sciences 14.9 (2013): 18925-18958.
[cited by applicant]
Esplin et al. “Personalized sequencing and the future of medicine: discovery, diagnosis and defeat of disease.” Pharmacogenomics 15.14 (2014): 1771-1790.
[cited by applicant]
Fahy et al. “Self-sustained sequence replication (3SR): an isothermal transcription-based amplification system alternative to PCR.” Genome Research 1.1 (1991): 25-33.
[cited by applicant]
Fairbrother et al. “RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons.” Nucleic acids research 32 (2004): W187-W190.
[cited by applicant]
FASTQ Format, Encyclopedia [online], Wikipedia, 2000. Retrieved from the Internet: <URL:https://en.wikipedia.org/wiki/FASTQ_format>, 11 pages.
[cited by applicant]
Fishel et al. “Meta-analysis of gene expression data: a predictor-based approach.” Bioinformatics 23.13 (2007): 1599-1606.
[cited by applicant]
Fluidigm. “Specification Sheet for Access Array System.” Datasheet [online], Fluidigm, 2012, 4 pages.
[cited by applicant]
Forshew et al. “Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.” Science translational medicine 4.136 (2012): 1-13.
[cited by applicant]
Forshew et al. “Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.” Supplementary Materials. Science translational medicine 4.136 (2012): 1-20.
[cited by applicant]
Fox et al. “Accuracy of next generation sequencing platforms.” Next generation, sequencing & applications 1 (2014): 1-9.
[cited by applicant]
Freed et al. “Somatic mosaicism in the human genome.” Genes 5.4 (2014): 1064-1094.
[cited by applicant]
Freshney, R. “Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications.” Sixth Edition, Hoboken, New Jersey, John Wiley & Sons (2010): 1-42.
[cited by applicant]
Frumkin et al. “Genomic variability within an organism exposes its cell lineage tree.” PLoS computational biology 1.5 (2005): 382-394.
[cited by applicant]
GATK. “Genome Analysis Toolkit: Variant Discovery in High-Throughput Sequencing Data.” Broad Institutes: GATK, 2025. Retrieved from the Internet: <URL:https://gatk.broadinstitute.org/hc/en-us>, 2 pages.
[cited by applicant]
Gilbert, S. “Developmental Biology Tenth Edition.” Sunderland, MA, Sinauer Associates, Inc. (2014): 1-12.
[cited by applicant]
Gnirke et al. “Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing.” Nature biotechnology 27.2 (2009): 182-189.
[cited by applicant]
Golob, J. “Mechanisms of cell fate acquisition in the differentiation of pluripotent stem cells.” University of Washington (2009): 1-126.
[cited by applicant]
Goris et al. “The immunogenetic architecture of autoimmune disease.” Cold Spring Harbor perspectives in biology 4.3 (2012): 1-15.
[cited by applicant]
Gottlieb et al. “The DiGeorge syndrome minimal critical region contains a goosecoid-like (GSCL) homeobox gene that is expressed early in human development.” American journal of human genetics 60.5 (1997): 1194-1201.
[cited by applicant]
Guan et al. “Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer.” Chinese journal of cancer 31.10 (2012): 463-470.
[cited by applicant]
Guo et al. “Exome sequencing generates high quality data in non-target regions.” BMC genomics 13 (2012): 1-10.
[cited by applicant]
Guo et al. “Exome sequencing generates high quality data in non-target regions.” BMC genomics 13, Supplementary Tables, (2012): 1-803.
[cited by applicant]
Guo et al. “Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation.” Nature genetics 45.12 (2013): 1459-1463.
[cited by applicant]
Haferlach et al. “Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype.” Leukemia 22.8 (2008): 1539-1541.
[cited by applicant]
Hamfjord et al. “Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing.” PloS one 7.4 (2012): 1-9.
[cited by applicant]
Hiratani et al. “Replication timing and transcriptional control: beyond cause and effect part II.” Current opinion in genetics & development 19.2 (2009): 142-149.
[cited by applicant]
Hirschhorn et al. “Human intersex with chromosome mosaicism of type XY/XO: Report of a case.” New England Journal of Medicine 263.21 (1960): 1044-1048.
[cited by applicant]
Hohaus et al. “Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas.” Annals of oncology 20.8 (2009): 1408-1413.
[cited by applicant]
Holstege et al. “Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis.” Genome research 24.5 (2014): 733-742.
[cited by applicant]
Hong et al. “Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.” Nature communications 6.1 (2015): 1-12.
[cited by applicant]
Huang et al. “Characterization of human plasma-derived exosomal RNAs by deep sequencing.” BMC genomics 14 (2013): 1-14.
[cited by applicant]
Huang et al. “Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy.” Scientific reports 8.1 (2018): 1-8.
[cited by applicant]
Huang et al. “SMuRF: portable and accurate ensemble prediction of somatic mutations.” Bioinformatics 35.17 (2019): 3157-3159.
[cited by applicant]
Human Genome Overview GRCh37, Datasheet [online], Genome Reference Consortium, 2009 [retrieved on Sep. 12, 2022]. Retrieved from the Internet: <URL:https://www.ncbi.nlm.nih.gov/grc/human>, 2 pages.
[cited by applicant]
Adessi et al. “Solid phase DNA amplification: characterisation of primer attachment and amplification mechanisms.” Nucleic acids research 28.20 (2000): 1-8.
[cited by applicant]
Agilent. “SureSelectXT Target Enrichment System for the Illumina Platform.” Datasheet [online], Agilent Technologies, 2021. Retrieved from the Internet: <URL:https://www.agilent.com/cs/library/usermanuals/public/G7530-9…
[cited by applicant]
Akey et al. “Haplotypes vs single marker linkage disequilibrium tests: what do we gain?” European Journal of Human Genetics 9.4 (2001): 291-300.
[cited by applicant]
Albert et al. “Direct selection of human genomic loci by microarray hybridization.” Nature methods 4.11 (2007): 903-905.
[cited by applicant]
Alter et al. “Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.” Journal of medical genetics 44.1 (2007): 1-9.
[cited by applicant]
Anderson et al. “Next generation DNA sequencing and the future of genomic medicine.” Genes 1.1 (2010): 38-69.
[cited by applicant]
Anonymous. “Cell Fate Map Adapted from Gilberts Developmental Biology, Fourth Edition, Figure 9.1.” Stack Exchange: Biology, Apr. 16, 2014. Retrieved from the Internet: <URL:https://biology.stackexchange.com/questions/1…
[cited by applicant]
Anzar et al. “NeoMutate: an ensemble machine learning framework for the prediction of somatic mutations in cancer.” BMC medical genomics 12 (2019): 1-14.
[cited by applicant]
ARUP. “Exome Sequencing Symptom-Guided Analysis.” ARUP Laboratories, 2013 [retrieved on Oct. 1, 2014]. Retrieved from the Internet: <URL:https://ltd.aruplab.com/Tests/Pub/2006332>, 2 pages.
[cited by applicant]
Asan et al. “Comprehensive comparison of three commercial human whole-exome capture platforms.” Genome biology 12 (2011): 1-12.
[cited by applicant]
Ausubel et al. “Current Protocols in Molecular Biology—Table of Contents.” New York, Greene Publishing Associates and Wiley-Interscience (1987): 1-8.
[cited by applicant]
Bainbridge et al. “Whole exome capture in solution with 3 Gbp of data.” Genome biology 11 (2010): 1-8.
[cited by applicant]
Baird et al. “Developing recombinant antibodies for biomarker detection.” Cancer Biomarkers 6.5-6 (2010): 271-279.
[cited by applicant]
Bamshad et al. “Exome sequencing as a tool for Mendelian disease gene discovery.” Nature Reviews Genetics 12.11 (2011): 745-755.
[cited by applicant]
BCL2FASTQ Conversion User Guide, Manual [online], Illumina, 2013. Retrieved from the Internet: <URL:https://support.illumina.com/content/dam/illumina-support/documents/documentation/software_documentation/bcl2fastq/bcl2…
[cited by applicant]
Beck et al. “Profile of the circulating DNA in apparently healthy individuals.” Clinical chemistry 55.4 (2009): 730-738.
[cited by applicant]
Behjati et al. “Genome sequencing of normal cells reveals developmental lineages and mutational processes.” Nature 513.7518 (2014): 422-425.
[cited by applicant]
Benesova et al. “Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients.” Analytical biochemistry 433.2 (2013): 227-234.
[cited by applicant]
Bent et al. “Enriching pathogen transcripts from infected samples: a capture-based approach to enhanced host pathogen RNA sequencing.” Analytical Biochemistry 438.1 (2013): 90-96.
[cited by applicant]
Bentley et al. “Accurate whole human genome sequencing using reversible terminator chemistry.” Nature 456.7218 (2008): 53-59.
[cited by applicant]